Outsourcing STREAM
-
How Sponsors Turn Disclosure As A Service Into A Strategic Advantage
5/18/2020
In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.
-
An Innovative Approach To Functional Outsourcing
8/27/2025
The shifting dynamics of clinical research from the current funding dynamic to the increased complexity of drug development, requires a different approach to functional outsourcing to be successful.
-
The Path Forward, Altasciences' Approach To Project Management
3/19/2024
Learn about a unique, integrated program management strategy that can lower your costs and reduce program timelines from lead candidate selection to clinical proof-of-concept by up to 40%.
-
Altasciences Has You Covered From Coast To Coast
1/30/2023
With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.
-
Navigating The Unique Attributes Of Psychedelic Drug Development
1/22/2024
Join our panel of experts for an in-depth review of the FDA's guidance on psychedelic drug development, exploring necessary methodological adaptations for safety, pharmacology, and efficacy.